Doctor profile · Federal record

Dr. Miguel Pelayo, M.D.

Medical Oncology Physician (CMS: Hematology/Oncology) · Hematology (Internal Medicine) Physician · Bradenton, FL

  • NPI 1912194283
  • Accepts Medicare
  • MIPS 75.0 / 100 · 2023
  • 21 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
5985 Silver Falls Run Ste 200
Bradenton, FL 342111291
(941) 907-4737
fax (941) 907-9493
Mailing address
Po Box 102222
Atlanta, GA 303682222

Credentials & registration

NPPES · NUCC
NPI registered
October 2007 — 19 yrs on file
Profile last updated
February 23, 2026
Year of graduation
2005 — 21 yrs since
Specialty taxonomy
207RX0202X — NUCC code
State license (1)
Florida #ME100373
Medicaid
FL #000424500

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1912194283. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
378,492
Distinct HCPCS
10
Medicare allowed
$3,562,624
HCPCS Description Services Patients Avg allowed
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 199,920 164 $1
J1756 Injection, iron sucrose, 1 mg 24,300 44 $0
J9271 Injection, pembrolizumab, 1 mg 22,400 27 $54
J0185 Injection, aprepitant, 1 mg 20,930 47 $2
J9263 Injection, oxaliplatin, 0.5 mg 15,286 15 $0
J0897 Injection, denosumab, 1 mg 13,440 139 $23
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj 10,260 12 $48
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units 10,150 53 $7
Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units 7,190 15 $8
J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg 6,076 15 $45

In context: peer comparison

Among 4 peers in Bradenton Medical Oncology Physician, average services per provider: 4,063. This provider delivers 93× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$794
Transactions
31
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Galvanize Therapeutics, INC 1 $123.55
Celgene Corporation 3 $117.40
Abbvie INC. 4 $84.38
Pfizer INC. 5 $83.05
Array Biopharma INC 3 $78.96
Janssen Biotech, INC. 3 $57.83
E.R. Squibb & Sons, L.L.C. 3 $56.53
Gilead Sciences, INC. 2 $47.77
Takeda Pharmaceuticals U.S.A., INC. 1 $33.33
Fennec Pharmaceuticals, INC. 1 $26.84
Pharmacosmos Therapeutics INC. 1 $22.24
Sumitomo Pharma America, INC. 1 $17.81
Exelixis INC. 1 $16.30
Genzyme Corporation 1 $14.70
Astellas Pharma US INC 1 $13.36

By nature of payment

Food and Beverage
$794

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
631
Patients
304
Total drug cost
$69,596
Drug Type Claims Patients Total cost
Anastrozole Generic 121 48 $3,221
Oxycodone Hcl Generic 72 26 $1,114
Prochlorperazine Maleate Generic 58 44 $1,160
Ondansetron Hcl Generic 50 36 $717
Eliquis (Apixaban) Brand 39 14 $27,878
Hydroxyurea Generic 39 16 $1,109
Lorazepam Generic 36 18 $289
Furosemide Generic 33 13 $125
Lidocaine-Prilocaine (Lidocaine/Prilocaine) Brand 32 25 $522
Prednisone Generic 32 12 $323

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Miguel Pelayo's medical specialty?
Dr. Miguel Pelayo practices Medical Oncology Physician in Bradenton, FL.
Where does Dr. Miguel Pelayo practice?
Dr. Miguel Pelayo practices at 5985 Silver Falls Run Ste 200, Bradenton, FL 342111291. Office phone: 9419074737.
What is Dr. Miguel Pelayo's NPI?
Dr. Miguel Pelayo's National Provider Identifier (NPI) is 1912194283, issued by NPPES.
Does Dr. Miguel Pelayo accept Medicare assignment?
Yes. Dr. Miguel Pelayo accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Miguel Pelayo commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, iron sucrose, 1 mg (HCPCS J1756); Injection, pembrolizumab, 1 mg (HCPCS J9271). Source: CMS Medicare Physician & Other Practitioners file.